Eterna Therapeutics Inc
ERNA
$2.40-3.61%
End of day · as of Oct 11, 2026, 8:01 AM ET
Mkt cap
$6.87M
EV/Sales
8.57
P/E ratio
N/A
FY2024 Revenue
$582,000
EPS (H1 2026)
$-9.63
Gross Margin (FY2024)
83.51%
Profit Margin (FY2024)
-7652.75%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M.
Use this ERNA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ERNA income, balance, and cash tables.
Eterna Therapeutics Inc (ERNA) is a biotechnology company in the Healthcare sector.
Latest cached Eterna Therapeutics Inc (ERNA) revenue for Dec 31, 2024 was $582.0K. Net income was -$44.5M. Statements: https://lician.com/financials/erna
Eterna Therapeutics Inc (ERNA) market capitalization is $6.9M on the latest cached snapshot.
Eterna Therapeutics Inc (ERNA) cached previous close $2.49; day range $2.25 – $2.49; volume 46,514. Session quote: https://lician.com/quote/erna
Eterna Therapeutics Inc (ERNA) latest cached earnings event is "ERNA earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings